Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
Antibody reactive against recombinant protein on ELISA. It has also been used for RNAi validation, and Western Blot.
Dilutions:
ELISA,
RNAi Validation,
Western Blot
Unit Size:
0.1 mg
Concentration:
Please see the vial label for concentration.
Notes:
This product is produced by and distributed for Abnova, a company based in Taiwan.
Packaging:
Storage:
Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Buffer:
Phosphate buffered saline, pH 7.2
Preservative:
No Preservative
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene.
Western blot analysis of AKT1 over-expressed 293 cell line. Lane 2 cotransfected with AKT1 Validated Chimera RNAi Lane 1 non-transfected control. Blot probed with H00000207-M01. GAPDH ( 36.1 kDa ) used as loading control.
Western blot analysis of AKT1 over-expressed 293 cell line. Lane 2 cotransfected with AKT1 Validated Chimera RNAi. Lane 1 non-transfected control. Blot probed with H00000207-M01. GAPDH (36.1 kDa) used as loading control.
Western blot analysis of AKT1 over-expressed 293 cell line. Lane 2 cotransfected with AKT1 Validated Chimera RNAi Lane 1 non-transfected control. Blot probed with H00000207-M01. GAPDH (36.1 kDa) used as loading control.